The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
A Dual‐Bioresponsive Drug‐Delivery Depot for Combination of Epigenetic Modulation and Immune Checkpoint Blockade
Abstract
Patients with advanced melanoma that is of low tumor‐associated antigen (TAA) expression often respond poorly to PD‐1/PD‐L1 blockade therapy. Epigenetic modulators, such as hypomethylation agents (HMAs), can enhance the antitumor immune response by inducing TAA expression. Here, a dual bioresponsive gel depot that can respond to the acidic pH and reactive oxygen species (ROS) within the tumor microenvironment (TME) for codelivery of anti‐PD1 antibody (aPD1) and Zebularine (Zeb), an HMA, is engineered. aPD1 is first loaded into pH‐sensitive calcium carbonate nanoparticles (CaCO 3 NPs), which are then encapsulated in the ROS‐responsive hydrogel together with Zeb (Zeb‐aPD1‐NPs‐Gel). It is demonstrated that this combination therapy increases the immunogenicity of cancer cells, and also plays roles in reversing immunosuppressive TME, which contributes to inhibiting the tumor growth and prolonging the survival time of B16F10‐melanoma‐bearing mice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Accumulating evidence indicates that chemotherapy, radiotherapy, angiogenesis inhibitor, stimulator of interferon genes (STING) agonist, fecal microbiota transplantation (FMT), epigenetic modulators, or other immunomodulators could synergize α-PD-1/PD-L1, by enhancing cancer antigen release, APC function, or effector activity [22–31].”
From Combination strategies with PD-1/PD-L1 blockade: current advances and future directions (2022) · cites this paper as [27]
Citations
Cites
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Garon, E. B., Rizvi, N. A., Hui, R., Leighl, N., Balmanoukian, A. S., Eder, J. P., Patnaik, A., Aggarwal, C., Gubens, M., Horn, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501824 · Cited by 6,198
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Motzer, R. J., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510665 · Cited by 5,807
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Sharma, P., Hu-Lieskovan, S., Wargo, J. A., & Ribas, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.017 · Cited by 5,588
The future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
El-Khoueiry, A. B., Sangro, B., Yau, T., Crocenzi, T. S., Kudo, M., Hsu, C., Kim, T.-Y., Choo, S.-P., Trojan, J., Welling, T. H., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31046-2 · Cited by 4,280
Topalian, S. L., Sznol, M., McDermott, D. F., Kluger, H. M., Carvajal, R. D., Sharfman, W. H., Brahmer, J. R., Lawrence, D. P., Atkins, M. B., Powderly, J. D., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.0105 · Cited by 2,222
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Gubin, M. M., Zhang, X., Schuster, H., Caron, E., Ward, J. P., Noguchi, T., Ivanova, Y., Hundal, J., Arthur, C. D., Krebber, W.-J., et al. (2014) · Nature · doi:10.1038/nature13988 · Cited by 1,974
Chen, Q., Xu, L., Liang, C., Wang, C., Peng, R., & Liu, Z. (2016) · Nature Communications · doi:10.1038/ncomms13193 · Cited by 1,612
Self-citationAnti–PD-1/PD-L1 therapy of human cancer: past, present, and future
Chen, L., & Han, X. N. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80011 · Cited by 1,455
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
Sanmamed, M. F., & Chen, L. (2018) · Cell · doi:10.1016/j.cell.2018.09.035 · Cited by 1,414
Flagged first, then by citations
Research works printed but not linked: 4
- Héninger E., 2015, Front. Immunol., 6, 29
- Gnyszka A., 2013, Anticancer Res., 33, 2989
- Sasaki M., 2001, Cancer Res., 61, 4809
- Nishiyama N., 2003, Cancer Res., 63, 8977
Cited by
Sorted by citations
Items 101–200 of 218
Immune Cycle‐Based Strategies for Cancer Immunotherapy
Li, Y., Liu, X., Zhang, X., Pan, W., Li, N., & Tang, B. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202107540 · Cited by 42
Biological signal integrated microfluidic hydrogel microspheres for promoting bone regeneration
Zhao, Z., Li, R., Ruan, H., Cai, Z., Zhuang, Y., Han, Z., Zhang, M., Cui, W., & Cai, M. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.135176 · Cited by 43
Self-citationZhou, H., Zhu, C., Zhao, Q. C., Ni, J., Zhang, H., Yang, G., Ge, J., Fang, C., Wei, H., Zhou, X., et al. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.05.022 · Cited by 42
Min, S., Jeon, Y. S., Jung, H. J., Khatua, C., Li, N., Bae, G., Choi, H., Hong, H., Shin, J. E., Ko, M. J., et al. (2020) · Advanced Materials · doi:10.1002/adma.202004300 · Cited by 41
Liang, X., Wang, D., Zhao, Y., Wang, X., Yao, S., Huang, W., Yang, Y., Dong, X., Zhang, L., & Yang, J. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02809-6 · Cited by 40
Jiang, J., Yan, Y., Yang, C., & Cai, H. (2025) · Biomedicines · doi:10.3390/biomedicines13040950 · Cited by 43
Choi, H., Bae, G., Khatua, C., Min, S., Jung, H. J., Li, N., Jun, I., Liu, H., Cho, Y., Na, K., et al. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202001446 · Cited by 38
Li, J., Zhang, P., Zhou, M., Liu, C., Huang, Y., & Li, L. (2022) · ACS Nano · doi:10.1021/acsnano.1c11562 · Cited by 37
Ding, H., Cui, Y., Yang, J., Li, Y., Zhang, H., Ju, S., Ren, X., Ding, C., & Zhao, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.03.060 · Cited by 37
Zuo, L., Ding, J., Li, C., Lin, F., Chen, P. R., Wang, P., Lu, G., Zhang, J., Huang, L., & Xie, H. (2020) · Chemical Science · doi:10.1039/c9sc05036a · Cited by 37
Microsphere‐containing Hydrogel Scaffolds for Tissue Engineering
Zhang, S., Lin, A., Tao, Z., Fu, Y., Xiao, L., Ruan, G., & Li, Y. (2022) · Chemistry - An Asian Journal · doi:10.1002/asia.202200630 · Cited by 36
Advances in PD-1 signaling inhibition-based nano-delivery systems for tumor therapy
Liu, S., Wang, H., Shao, X., Chen, H., Chao, S., Zhang, Y., Gao, Z., Yao, Q., & Zhang, P. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01966-4 · Cited by 36
Stable and Biocompatible Cellulose-Based CaCO3 Microspheres for Tunable pH-Responsive Drug Delivery
Yan, G., Feng, Y., Gao, Z., Zeng, X., Hong, W., Liu, W., Sun, Y. Q., Tang, X., Lei, T., & Lin, L. (2019) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.9b05144 · Cited by 36
Wang, M., Zhou, B., Wang, L., Zhou, F., Smith, N., Saunders, D., Towner, R. A., Song, J., Qu, J., & Chen, W. R. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb01453b · Cited by 36
Yang, A., Dong, X., Bai, Y., Sheng, S., Zhang, Y., Liu, T., Zhu, D., & Lv, F. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.129192 · Cited by 36
Sun, S., Yu, M., Liu, Y., Huang, W., Zhu, M., Fu, Y., Yan, L., Wang, Q., Ji, X., Zhao, J., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122068 · Cited by 35
Xue, C., Li, M., Sutrisno, L., Yan, B., Zhao, Y., Hu, Y., Cai, K., Zhao, Y., Yu, S., & Luo, Z. Y. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202008732 · Cited by 35
Chen, M., Juengpanich, S., Li, S., Topatana, W., Lu, Z., Zheng, Q., Cao, J., Hu, J., Chan, E., Hou, L., et al. (2022) · Advanced Science · doi:10.1002/advs.202103895 · Cited by 35
Self-citationTargeting the Epigenome in Malignant Melanoma: Facts, Challenges and Therapeutic Promises
Anestopoulos, I., Kyriakou, S., Tragkola, V., Paraskevaidis, I., Tzika, E., Mitsiogianni, M., Deligiorgi, M. V., Petrakis, G., Trafalis, D. T., Botaitis, S., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108301 · Cited by 36
Yuan, W., Huang, C., Deng, W., Lai, J., Chen, J., Jie, J., Wu, Y., You, T., & Wu, L. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135562 · Cited by 34
Zhang, S., Feng, Y., Meng, M., Li, Z., Li, H., Lin, L., Xu, C., Chen, J., Hao, K., Tang, Z., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121794 · Cited by 34
Application of injectable hydrogels in cancer immunotherapy
Liu, C., Liao, Y., Liu, L., Xie, L., Liu, J., Zhang, Y., & Li, Y. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1121887 · Cited by 33
Advances in 3D culture systems for therapeutic discovery and development in brain cancer
Wanigasekara, J., Cullen, P. J., Bourke, P., Tiwari, B. K., & Curtin, J. F. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103426 · Cited by 33
Lin, Z., Ding, J., Chen, X., & He, C. (2023) · Chemistry - An Asian Journal · doi:10.1002/asia.202300021 · Cited by 33
In Situ Antigen‐Capturing Nanochaperone Toward Personalized Nanovaccine for Cancer Immunotherapy
Li, X., Zhang, Y., Wu, X., Chen, J., Yang, M., Ma, F., & Shi, L. (2022) · Small · doi:10.1002/smll.202203100 · Cited by 32
Genome-Editing-Mediated Restructuring of Tumor Immune Microenvironment for Prevention of Metastasis
Kim, D.-Y., Wu, Y., Shim, G., & Oh, Y. (2021) · ACS Nano · doi:10.1021/acsnano.1c05420 · Cited by 31
Wen, Y., Liu, Y., Chen, C., Chi, J., Zhong, L., Zhao, Y., & Zhao, Y. (2020) · Biomaterials Science · doi:10.1039/d0bm01931c · Cited by 31
Qiu, W., Liang, M., Gao, Y., Yang, X., Zhang, X., Zhang, X., Xue, P., Kang, Y., & Xu, Z. (2021) · Theranostics · doi:10.7150/thno.64354 · Cited by 30
Lu, D., Li, W., Tan, J., Li, Y., Mao, W., Zheng, Y., Yang, M., Wang, J., Wang, W., Wang, S., et al. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c09825 · Cited by 29
Self-citationZhang, N., Wang, D., Jing, X., Yang, T., Yang, H., & Meng, L. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00569 · Cited by 29
CaCO 3 nanoplatform for cancer treatment: drug delivery and combination therapy
Yang, X., Sun, Y., Zhang, H., Liu, F., Chen, Q., Shen, Q., Kong, Z., Wei, Q., Shen, J., & Guo, Y. (2024) · Nanoscale · doi:10.1039/d3nr05986c · Cited by 30
Self-citationDesigning and Engineering of Nanocarriers for Bioapplication in Cancer Immunotherapy
Li, Y., Zhang, X., Liu, X., Pan, W., Li, N., & Tang, B. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01272 · Cited by 29
Injectable hydrogels as drug delivery platform for in-situ treatment of malignant tumor
Ma, Q., Li, Q., Cai, X., Zhou, P., Wu, Z., Wang, B., Ma, W., & Fu, S. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103817 · Cited by 27
Extracellular Vesicles for Disease Treatment
Wang, F., Feng, J., Jin, A., Shao, Y., Shen, M., Ma, J., Lei, L., & Liu, L. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s506456 · Cited by 26
Nanotechnologies for enhancing cancer immunotherapy
Yang, J., Wang, C., Shi, S., & Dong, C. (2020) · Nano Research · doi:10.1007/s12274-020-2904-8 · Cited by 26
Development of cancer immunotherapy based on PD-1/PD-L1 pathway blockade
Zhang, M., Liu, K., & Wang, M. (2019) · RSC Advances · doi:10.1039/c9ra04590b · Cited by 26
Wang, L., Mei, Z., Jin, G.-Y., Liu, H., Lv, S., Fu, R., Li, M., & Yao, C. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.06.034 · Cited by 26
Chen, G., Wang, Y., Mo, L., Xu, X., Zhang, X., Yang, S., Huang, R., Li, R., Zhang, L., & Zhang, B. (2024) · ACS Nano · doi:10.1021/acsnano.4c04045 · Cited by 25
Self-citationInjectable Micelle-Incorporated Hydrogels for the Localized Chemo-Immunotherapy of Breast Tumors
Qin, X., He, L., Feng, C., Fan, D., Liang, W., Wang, Q., & Fang, J. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c11563 · Cited by 24
Applications of pyroptosis activators in tumor immunotherapy
Bao, X., Sun, M., Meng, L., Zhang, H., Yi, X., & Zhang, P. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101191 · Cited by 24
Zhao, Y. G., Liu, S., Shi, Z., Zhu, H., Li, M., & Yu, Q. (2022) · Nano Research · doi:10.1007/s12274-022-4211-z · Cited by 23
Versatile hydrogel-based drug delivery platform for multimodal cancer therapy from bench to bedside
Mei, Y., Hu, J., Cao, Y., Gao, X., Tang, L., & Wang, W. (2024) · Applied Materials Today · doi:10.1016/j.apmt.2024.102341 · Cited by 25
The blooming intersection of transcatheter hepatic artery chemoembolization and nanomedicine
Chen, H., Cheng, H., Wu, W., Li, D., Mao, J., Chu, C., & Liu, G. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.03.024 · Cited by 23
Self-citationResearch progress in tumor targeted immunotherapy
Fang, Y., Yu, A., Ye, L., & Zhai, G. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1882992 · Cited by 23
Li, S., Chen, X., Guan, S., Wang, Z., Cao, W., Luo, G., & Ling, X. (2023) · ACS Nano · doi:10.1021/acsnano.3c04785 · Cited by 21
Huang, X., & Zhang, W. (2023) · Small Methods · doi:10.1002/smtd.202301326 · Cited by 21
Zhang, L. L., Zhu, C., Zhao, J., Scimeca, L., Dong, M., Liu, R., Jia, Y., & Xu, Z. P. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202311914 · Cited by 21
Engineering SIRPα cellular membrane-based nanovesicles for combination immunotherapy
Wang, M., Wang, Y., Mu, Y., Yang, F., Yang, Z., Liu, Y., Huang, L., Liu, S., Guan, X., Xie, Z., et al. (2023) · Nano Research · doi:10.1007/s12274-023-5397-4 · Cited by 21
Self-citationChen, X., Ding, W., Jiang, Y., Shi, W., Qiu, Y., Zhao, H., & Luo, X. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c12603 · Cited by 20
Injectable immunogel based on polymerized phenylboronic acid and mannan for cancer immunotherapy
Kim, S., Lee, J., Im, S., & Kim, W. J. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.009 · Cited by 20
Peritumoral scaffold neutralizes tumor pH for chemotherapy sensitization and metastasis inhibition
Yan, Y., Li, J., Yi, X., Liu, C., Zhou, Z., Huang, Y., & Li, L. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.11.006 · Cited by 20
Wang, M., Yu, Z., Feng, H., Wang, J., Wang, L., Zhang, Y., Yin, L., Du, Y., Jiang, H., Wang, X., et al. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01070j · Cited by 20
Self-citationA cell-laden hydrogel as prophylactic vaccine and anti-PD-L1 amplifier against autologous tumors
Li, J., Yan, Y., Zhang, P., Ding, J., Huang, Y., Jin, Y., & Li, L. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.027 · Cited by 18
Wang, Z., Xiong, H., Zhai, Z., Yao, Y., Zhou, T., Zhang, H., Fan, C., & Gao, C. (2022) · Nano Research · doi:10.1007/s12274-022-4934-x · Cited by 18
Qi, J., Ding, T., Liu, T., Xia, X., Wu, S., Liu, J., Chen, Q., Zhang, D., & Zhao, H. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202204273 · Cited by 18
Self-citation“Cold” colorectal cancer faces a bottleneck in immunotherapy
Liu, J., Yang, M., Bai, J., Liu, Z., & Wang, X. (2023) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v15.i2.240 · Cited by 20
Pang, X., Liang, S., Wang, T., Yu, S., Yang, R., Hou, T., Liu, Y., He, C., & Zhang, N. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s253990 · Cited by 17
Zhao, Y., Song, S., Zhang, J., Ren, X., & Zhao, Y. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00923 · Cited by 17
Gao, T., Fu, S., Quan, X., Sun, J., Jiang, M., & Li, J. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s566173 · Cited by 17
Zhang, W., Wei, Y., Wei, Q., Zhao, Y., Jin, Z., Wang, Y., Ma, G., He, X., Hu, Z., & Jiang, Y. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125793 · Cited by 16
Two-pronged anti-cancer nanovaccines enpowered by exogenous/endogenous tumor-associated antigens
Yin, M., Liu, Z., Zhou, Y., Li, W., Yan, J., Cao, D., & Yin, L. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.07.024 · Cited by 16
Fu, H., Huang, L., Xu, C., Zhang, J., Li, D., Ding, L., Liu, L., Dong, Y. W., Wang, W., & Duan, Y. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102062 · Cited by 16
Structurally Tunable pH-responsive Phosphine Oxide Based Gels by Facile Synthesis Strategy
Nazir, R., Parida, D., Guex, A. G., Rentsch, D., Zarei, A., Gooneie, A., Salmeia, K. A., Yar, K. M., Alihosseini, F., Sadeghpour, A., et al. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b22808 · Cited by 16
Local immunotherapy of glioblastoma: A comprehensive review of the concept
Sabahi, M., Salehipour, A., Bazl, M. S. Y., Rezaei, N., Mansouri, A., & Borghei-Razavi, H. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578146 · Cited by 15
Nano‐Regulator Inhibits Tumor Immune Escape via the “Two‐Way Regulation” Epigenetic Therapy Strategy
Liang, S., Liu, M., Mu, W., Gao, T., Gao, S., Fu, S., Yuan, S., Liu, J., Liu, Y., Jiang, D., et al. (2023) · Advanced Science · doi:10.1002/advs.202305275 · Cited by 15
Tang, Z., Xu, Y., Li, J., Mai, H., Chen, R., Fu, J., Wang, P., Zhong, Q., Xie, J., Ning, Y., et al. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c07716 · Cited by 14
Self-citationYang, G., Ni, J., Li, Y., Zha, M., Tu, Y., & Li, K. (2020) · Angewandte Chemie · doi:10.1002/ange.202013228 · Cited by 14
Oral biomimetic virus vaccine hydrogel for robust abscopal antitumour efficacy
Wang, C., Tang, H., Duan, Y., Zhang, Q., Shan, W., Wang, X., & Ren, L. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.06.102 · Cited by 14
Efficient Gene Delivery Based on Guanidyl‐Nucleic Acid Molecular Interactions
Wang, D., Song, J., Wang, J., Zhang, Z., Shen, Q. X., Wang, J., Guo, H., Wang, R., Xie, C., Lu, W., et al. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202004783 · Cited by 14
Self-citationGang, F., Yan, H., Ma, C., Jiang, L., Gu, Y., Liu, Z., Zhao, L., Wang, X., Zhang, J., & Sun, X. (2019) · Chemical Communications · doi:10.1039/c9cc90441g · Cited by 14
Huang, C., Zhao, C., Sun, Y., Feng, T., Ren, J., & Qu, X. (2024) · Nano Letters · doi:10.1021/acs.nanolett.4c01794 · Cited by 13
Xu, T., Gan, L., Chen, W., Zheng, D., Li, H., Deng, S., Qian, D., Gu, T., Lian, Q., Shen, G., et al. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.10.031 · Cited by 13
Self-citationBlood compatibility evaluations of CaCO 3 particles
Lin, J., Huang, L., Xiang, R., Ou, H., Li, X., Chen, A., & Liu, Z. (2021) · Biomedical Materials · doi:10.1088/1748-605x/ac19bf · Cited by 13
Ma, C., Ding, W., Li, P., Wang, Q., Li, X., Meng, Z., & Ren, H. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c18140 · Cited by 12
Multi‐Functional Supramolecular‐Polymeric Hybrid Hydrogel for Promoting Cutaneous Wound Repair†
Wei, Q., Jia, L., Wang, Y., Zhang, W., Hu, Z., Wang, Q., & Wu, Q. (2023) · Chinese Journal of Chemistry · doi:10.1002/cjoc.202300264 · Cited by 12
Kim, S., Yun, S., Doh, J., & Kim, H. N. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400475 · Cited by 10
Stimuli-Responsive Drug Delivery Systems for Enhanced Melanoma Immunotherapy
Zhang, G., Zhang, X., Dong, Q., Kong, S., Chen, L., Zhang, X., Gao, J.-Q., Zhang, J., & Ding, B. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s517331 · Cited by 11
Xiao, B., Shi, X., Xu, X., Liu, J., Pan, Y., Xu, H., Sun, W., Slater, N. K. H., Patra, H. K., Gao, J.-Q., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.08.043 · Cited by 9
Peng, N., Du, Y., Liu, J., Li, D., Li, Y., Deng, K., Li, L., Jia, P., Min, J., & Lin, J. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c10363 · Cited by 9
Hsu, R., Fang, J., Shen, W., Sheu, Y.-C., Su, C., Chiang, W., & Hu, S. (2020) · Nanoscale · doi:10.1039/d0nr01185a · Cited by 9
Reprogramming tumor-immune cell communication with a radiosensitive nanoregulator for immunotherapy
Chen, Y., Liu, S., Gao, P., Pan, W., Shi, M., Wang, J., Li, N., & Tang, B. (2022) · Science China Materials · doi:10.1007/s40843-022-2140-7 · Cited by 9
Self-citationWang, J., Li, T., Ni, J., Guo, H., Kang, T., Li, Z., Zha, M., Lu, S., Zhang, C., Qi, W., et al. (2021) · Advanced Science · doi:10.1002/advs.202100228 · Cited by 9
Self-citationInnovative approaches to melanoma treatment: a spotlight on stimuli-responsive biomaterials
Chitakunye, A. T., Ezekiel, O. C., Liu, Q., Zhang, S., Zhu, Q., & Cai, L. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb01504e · Cited by 7
Li, M., Sun, Y., Hu, C., Luo, H., Li, M., & Yang, Y. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102331 · Cited by 7
Nanoantidote for repression of acidosis pH promoting COVID‐19 infection
Liu, Q., Ruan, H., Sheng, Z., Sun, X., Li, S., Cui, W., & Li, C. (2022) · Open Research (University of Surrey) · doi:10.1002/viw.20220004 · Cited by 7
Self-citationCho, K. J., Cho, Y., & Kim, J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122752 · Cited by 7
Kou, X., He, T., Zhang, M., Wu, X., Li, X., Luo, R., Wu, R., Gou, X., Shen, M., Wu, Q., et al. (2023) · Small Methods · doi:10.1002/smtd.202300019 · Cited by 7
Huynh, V. A., Tatari, N., Marple, A. S. T., Savage, N. J., McKenna, D., Venugopal, C., Singh, S. K., & Wylie, R. G. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.040 · Cited by 7
Breaking Immunosuppressive Barriers by Engineered Nanoplatforms for Turning Cold Tumor to Hot
Dong, J., Huang, Y., Zhou, Z., & Sun, M. (2022) · Advanced Therapeutics · doi:10.1002/adtp.202200020 · Cited by 7
Wu, Y., Zheng, W., Li, X., Wu, S., Zhou, L., Zhang, D., & Chen, Z. (2026) · RSC Advances · doi:10.1039/d6ra00728g · Cited by 6
Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
Sun, S., Shi, D., Liu, J., Lu, J., Dou, P., Zhou, Z., & Chen, Y. (2023) · Journal of Visualized Experiments · doi:10.3791/65026 · Cited by 6
Biomaterials-assisted cancer vaccine delivery: preclinical landscape, challenges, and opportunities
Chen, M., Zhou, Y. X., Fù, Y., Wang, Q., Wu, C., Pan, X., & Quan, G. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2388832 · Cited by 5
A drug-delivery depot for epigenetic modulation and enhanced cancer immunotherapy
Lai, J., Liang, J., Zhang, Y., Zhang, B., Wei, J., Fan, J., Chen, L., Chen, Z., Li, Q., Guo, D., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115687 · Cited by 6
Self-citationNext Generation of Cancer Immunotherapy: Targeting the Cancer-Immunity Cycle with Nanotechnology
Ma, Y., & Cai, L. (2020) · Springer eBooks · doi:10.1007/978-981-15-5386-8_4 · Cited by 5
Life Engineering of Materials: Artificial Materials as Plugins for Biological Regulations
Lin, J., Hu, L., Wang, X., & Tang, R. (2025) · Advanced Materials · doi:10.1002/adma.202505767 · Cited by 4
Jin, Q., Lin, S.-Q., Xue, X.-J., Wang, L.-L., Jiang, M.-Y., Wang, J., Wu, S.-F., & Hu, Y.-Y. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s535220 · Cited by 4
Self-citationYang, Q., Zhong, Y., Cai, S., Sheng, Z., Sun, D., Chen, P., Zhang, Y., Li, J., Wu, W., & Zhang, M. (2026) · Nano Research · doi:10.26599/nr.2026.94908472 · Cited by 3
Liu, X., Wang, M., Yan, J., Wu, F., Zhao, Z., Yang, Q., Zhou, R., Zheng, Y., Zhu, R., Chen, Y., et al. (2023) · Advanced NanoBiomed Research · doi:10.1002/anbr.202200175 · Cited by 3
Immune checkpoint blocking in cancer therapy using thermosensitive hydrogels: a review
Tayebi-Khorrami, V., Fadaei, M. R., Fallahianshafiei, S., & Askari, V. R. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04171-2 · Cited by 3
Wang, J., & Xu, A. (2025) · Pharmaceuticals · doi:10.3390/ph18101487 · Cited by 2
Self-citation
Metadata
- Authors
- Ruan, H., Hu, Q., Wen, D., Chen, Q., Chen, G., Lu, Y., Wang, J., Cheng, H., Lu, W., & Gu, Z.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Department of Bioengineering University of California Los Angeles CA 90095 USA
- Drexel University (US)
- Fudan University (CN)
- Corresponding author
- Lu, Weiyue
- Gu, Zhen
- ORCID
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2019-03-11
- Volume
- 31
- Issue
- 17
- Pages
- e1806957-e1806957
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W2922000375
- Cited by
- 220
- References
- 55
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 31 · 2023: 32 · 2022: 40 · 2021: 38 · 2020: 39 · 2019: 17
- FWCI
- 11.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Advanced Materials (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of North Carolina at Chapel Hill
- Alfred P. Sloan Foundation
- National Natural Science Foundation of China (81690263)
- China Scholarship Council
- Topics
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- advanced melanoma, epigenetic modulation, zebularine, PD-1/PD-L1 blockade, anti-PD-1, ROS-responsive hydrogel, tumor microenvironment, tumor-associated antigen expression, immunosuppressive tumor microenvironment, combination immunotherapy, B16F10 melanoma
- MeSH terms
- Animals, Antibodies, Monoclonal, Antineoplastic Agents, Calcium Carbonate, Cytidine, Drug Therapy, Combination, Humans, Hydrogen-Ion Concentration, Immunosuppressive Agents, Immunotherapy, Melanoma, Drug Delivery Systems, Reactive Oxygen Species, Cell Line, Tumor, Nanoparticles, Tumor Microenvironment, Programmed Cell Death 1 Receptor, Antibodies, Monoclonal, Humanized, Drug Liberation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review